House Ways & Means Tackles Critical Minerals for Biden’s Post-Fossil Fuels Economy
The U.S. has passed laws promoting the use of electric vehicles and battery manufacturing. But where will all the raw materials come from?
The U.S. has passed laws promoting the use of electric vehicles and battery manufacturing. But where will all the raw materials come from?
The recent spending on manufacturing facilities is almost entirely due to two pieces of legislation. That won’t be enough for a real, manufacturing boom.
The U.S. trade deficit remains on par to crack $1 trillion again. Meanwhile, a soft decoupling from China can be seen in the latest trade data.
Key Points The Section 301 tariffs imposed in 2018 on Chinese imports reduced U.S. dependence on China. While U.S. imports surged by 39% between 2017 and 2022, China imports were up very slightly, and still below their 2018 peak. As a result, China fell from 21.6% of U.S. imports in 2017 to just 16.5% in…
The China tariffs, enacted by Lighthizer under Trump, are under review later this year. Will they stay or will they go? Lighthizer thinks they should stay…with more tariffs added.
The House Select Committee on the CCP published a preliminary report on the use of forced labor in Shein and Temu supply chains. Many Americans are investors.
Don’t blame the China tariffs on inflation. Supply chain snafus were a much bigger deal, a Federal Reserve report says.
On June 1, 2023, the United States and Taiwan signed “the first agreement under the U.S.-Taiwan Initiative on 21st Century Trade.” “Initiative”? “21st Century Trade”? Sleepy terms that convey a classic “nothing-burger”. But that’s never been the case with trade agreements. This agreement, ostensibly for Taiwan, sets out expectations for how the U.S. and Taiwan…
At National Press Club, Katherine Tai talks about supply chain issues, what ‘de-risking’ from China might look like, and how USTR thinks about it.
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?